Technology
Health
Biotechnology

Seelos Therapeutics

$1.58
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell SEEL and other stocks, options, ETFs, and crypto commission-free!

About SEEL

Seelos Therapeutics, Inc. Common Stock, also called Seelos Therapeutics, is a clinical-stage biopharmaceutical company. Read More It focuses on development and advancement of novel therapeutics to address unmet medical needs for the benefit of patients with central nervous system disorders. Its portfolio include late-stage clinical assets targeting psychiatric and movement disorders. The company is headquartered in New York, NY.

Employees
5
Headquarters
New York, New York
Founded
Market Cap
35.51M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
230.23K
High Today
$1.63
Low Today
$1.53
Open Price
$1.53
Volume
97.48K
52 Week High
$12.82
52 Week Low
$1.32

Collections

Technology
Health
Biotechnology
Medical
Therapy
Biopharmaceutical
Pharmaceutical
US

SEEL Earnings

-$3.98
-$2.67
-$1.36
-$0.05
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
-$0.09 per share
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.